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Abstract
Background: Type 2 diabetes mellitus (T2DM) is a complex endocrine and metabolic disorder. Recently, several
genome-wide association studies (GWAS) have identified many novel susceptibility loci for T2DM, and indicated
that there are common genetic causes contributing to the susceptibility to T2DM in multiple populations
worldwide. In addition, clinical and epidemiological studies have indicated that obesity is a major risk factor for
T2DM. However, the prevalence of obesity varies among the various ethnic groups. We aimed to determine the
combined effects of these susceptibility loci and obesity/overweight for development of T2DM in the Japanese.
Methods: Single nucleotide polymorphisms (SNPs) in or near 17 susceptibility loci for T2DM, identified through
GWAS in Caucasian and Asian populations, were genotyped in 333 cases with T2DM and 417 control subjects.
Results: We confirmed that the cumulative number of risk alleles based on 17 susceptibility loci for T2DM was an
important risk factor in the development of T2DM in Japanese population (P < 0.0001), although the effect of each
risk allele was relatively small. In addition, the significant association between an increased number of risk alleles
and an increased risk of T2DM was observed in the non-obese group (P < 0.0001 for trend), but not in the obese/
overweight group (P = 0.88 for trend).
Conclusions: Our findings indicate that there is an etiological heterogeneity of T2DM between obese/overweight
and non-obese subjects.
Background
Type 2 diabetes mellitus (T2DM) is a complex endo-
crine and metabolic disorder. The interaction between
multiple genetic and environmental factors is considered
to contribute to the pathogenesis of the disease [1-3].
Most patients with T2DM suffer serious complications
due to chronic hyperglycemia, including nephropathy,
neuropathy, retinopathy and accelerated development of
cardiovascular disease.
The prevalence of type 2 diabetes is continuing to
increase in many countries, including Japan [4,5].
Clinical and epidemiological studies have indicated that
obesity is a major risk factor for T2DM, because obesity
is associated with an increased risk of developing insulin
resistance and impaired glucose tolerance [6,7]. When
b-cells are no longer able to secrete sufficient amounts
of insulin to overcome insulin resistance, impaired glu-
cose tolerance progresses to T2DM [7].
The prevalence of obesity is also increasing worldwide,
although there are large ethnic differences in the degree
of obesity reached. In Japan, the prevalence of severe
obesity (BMI ≥ 30 kg/m
2) is lower than that in Western
countries, where the prevalence of overweight (25 ≤
BMI < 30) adults has been steadily increasing [5,8]. It is
thought that genetically, insulin secretion compensation
for insulin resistance is weaker in the Japanese than in
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veys a risk factor for diabetes in Japan [8]. In fact, the
prevalence of T2DM in the Japanese population is as
high as in Western countries, although the prevalence of
obesity is much lower than that seen in Caucasians
[4,5,8,9].
Recently, several genome-wide association studies
(GWAS) have identified many novel susceptibility genes
for T2D. To date, approximately 40 susceptibility loci
for type 2 diabetes have been identified [10-17]. Most of
these susceptibility loci were detected in Caucasians,
and they have been widely confirmed to be susceptible
loci for T2DM in Asian populations [17-23]. Further-
more, additional GWAS for Japanese and Chinese popu-
lations were performed and new susceptibility loci were
detected [24-28], some of which have also been con-
firmed in Caucasians as well as Asian populations
[24,25,29]. Thus, GWAS indicate that there are common
genetic causes contributing to the susceptibility to
T2DM in multiple populations worldwide, although
clinical risk factors, such as BMI and insulin secretion
levels, vary among the various ethnic groups with differ-
ent genetic backgrounds or life styles [5]. Furthermore,
most of the susceptibility loci identified through GWAS
to date are likely to affect insulin secretion and b-cell
function, while a few are potentially involved in insulin
action [30,31].
In the present study, we analyzed the relationships
between the genotypes of 17 susceptibility loci identified
by GWAS and T2DM in a Japanese population-based
case-control study. We alsoe x a m i n e dt h ec o m b i n e d
effect of the cumulative number of risk alleles of the
T2DM and obesity/overweight for the development of
T2DM.
Methods
Subjects
This is a population based case-control study. The parti-
cipants for this study were recruited from Japanese who
underwent a routine medical check-up at a medical cen-
ter near the University of Shizuoka on 2005. We have
selected men (N = 6094) under 65 years of age as sub-
jects in this study. Of these, 378 men (6.2%) were diag-
nosed with T2DM by physicians according to the World
Health Organization (WHO) diagnostic criteria for
T2DM (http://www.who.int/diabetes/publications/diag-
nosis_diabetes2006/en/). Of them, 333 men were
included as T2DM subjects in this study, as complete
genotype information on all 17 SNPs analyzed in this
study was obtained. For the control subjects, 417 men
(aged 45 to 65 years) were randomly selected from all
subjects according to the following criteria: (1) their
fasting plasma glucose levels were under 100 mg/dl (5.6
mmol/1), (2) their HbA1c levels were under 5.8%, and
(3) complete genotype information on all 17 SNPs was
obtained. All subjects provided written informed con-
sent to participate in this study, and the study was
approved by the Ethics Committee of the University of
Shizuoka.
After overnight fasting, blood was collected from each
subject. The clinical characteristics of the subjects were
determined according to the medical check-up protocol.
DNA analysis
Genomic DNA was isolated from peripheral leucocytes
by the phenol extraction method. We analyzed the gen-
otypes of 17 SNPs in or near 17 susceptibility loci for
T2DM. At first, we selected 10 susceptibility loci
(SLC30A8, CDKN2A/B, KCNJ11, IGF2BP2, CDKAL1,
HNF1B, HHEX, FTO, TCF7L2, PPARG), which had been
detected in the first stage of GWAS for Caucasian [14],
and four loci (CDC123, ADAMTS9, TSPAN8, JAFZ),
which had been detected in a meta-analysis of three
large GWAS [15], because they had been confirmed in
several replication studies [17-23]. In addition, three
SNPs (KCNQ1, C2CD4A, UBE2E2), which were discov-
ered in GWAS using Japanese people, were examined
[24,25,28]. However, three loci (WFS1, NOTCH2,
THADA) which were also ascertained to be associated
with T2DM in the first stage GWAS or the meta-analy-
sis of three large GWAS [14,15], were excluded from
this analysis due to low minor allele frequencies in Japa-
nese (< 0.03) [17,23]. Although more and more suscept-
ibility loci for T2DM are being identified, we have not
yet examined such new susceptibility loci.
The genotypes of these 17 susceptibility loci were
determined for each subject using the PCR-restriction
fragment length polymorphism method. The genotype
call rate for each SNP was > 95%. The genotype distri-
butions of these 17 SNPs were in Hardy-Weinberg equi-
librium (P > 0.05).
Statistical analyses
Each risk allele was defined as the allele associated with
increased risk of T2DM in previous studies [23,28]. The
each allele-specific odds ratios (ORs) with 95% confi-
dence intervals (CIs) and P-values for T2DM were cal-
culated under the assumption of an additive model
using logistic regression analysis, adjusting for age and
BMI. In addition, the cumulative number of risk alleles
was counted, in which individuals homozygous for non-
risk alleles were coded as 0, heterozygous individuals
were coded as 1 and individuals homozygous for the
risk alleles were coded as 2, with the assumption that
each risk allele acted independently and contributed
equally to the risk of T2DM. The effects of the cumula-
tive number of risk alleles, BMI or obesity/overweight,
and the interaction between the cumulative number of
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lence of T2DM were assessed using multivariate logistic
regression analysis.
Statistical analyses were performed using the JMP
software package (SAS Institute, Cary, NC). The power
to detect an association between each SNP and T2DM
was estimated under current sample size and minor
allele frequency observed in this study using “Quanto”
(http://hydra.usc.edu/gxe/), assuming OR = 1.2 and a
level = 0.05 (one-sided). The Cochran-Armitage test was
used to examine the trend of an increase in the OR by
an increasing number of the risk alleles.
Results
The characteristics of our subjects are presented in
Table 1. Of the total 6094 subjects, the prevalence of
diabetes, obesity, and being overweight were 6.2%, 2.6%,
and 27.0%, respectively. The BMI, blood pressure, serum
triglyceride, glucose and HbA1c were higher, and HDL-
cholesterol was lower, in subjects with T2DM compared
with control subjects.
We then analyzed the relationships between common
genetic variants of 17 T2DM susceptibility loci that have
been previously detected by GWAS and T2DM in Japa-
nese men. Table 2 shows the risk allele frequencies of
each SNP, and risk allele-specific OR, P-value and esti-
mated power to detect the association, assuming OR =
1.2. The ORs and P-values were adjusted for age and
BMI in a logistic regression analysis. Four risk alleles for
SLC30A8, CDKN2A/B, CDC123,a n dKCNQ1 were sig-
nificantly associated with T2DM (P <0 . 0 5 ) ,a l t h o u g h
three of them were not significant when Bonferroni’s
correction for multiple testing applied (significance level,
0.05/17 = 0.0029). Of the remaining loci, except for
PPARG, ADAMTS9, TSPAN8 and JAZF1, the risk allele
frequencies of T2DM subjects were higher than that of
control subjects, although not statistically significant.
Next, we calculated the cumulative number of these
17 risk alleles that each subject possessed. The distribu-
tion of the cumulative number of risk alleles in T2DM
s u b j e c t ss h i f t e dt ot h er i g h tc o m p a r e dw i t ht h a to ft h e
control subjects. The mean risk allele number in T2DM
subjects (16.7 ± 2.5) was significantly higher than that in
control subjects (15.6 ± 2.4) (P < 0.0001, t-test) (Figure
1). Multivariable regression analyses indicated that both
the cumulative number of risk alleles and BMI or obe-
sity/overweight were important predictors of T2DM (P
< 0.0001). In addition, we found interactions between
the cumulative number of risk alleles and BMI or obe-
sity/overweight for developing T2DM (P = 0.0080 or P
= 0.015, respectively) (Table 3). And the cumulative
number of risk alleles was not an independent predictor
of T2DM when the interaction between the number of
risk alleles and obesity/overweight was incorporated in
the regression model as a covariate (P =0 . 8 1 )( T a b l e3 ,
Model 4).
To examine the relationships between an increased
number of risk alleles and T2DM, we stratified the sub-
jects into four groups by quartiles of the risk allele num-
bers (Q1, ≤ 14; Q2, 15, 16; Q3, 17, 18; and Q4, ≥ 19,
respectively). The OR associated with each quartile
group compared with the reference group (Q1) are
shown in Table 4. An increased number of risk alleles
was associated with an increased risk of T2DM (P <
0.0001 for trend).
Furthermore, to test for an interaction between the
number of risk alleles and obesity/overweight on T2DM
risk, we divided the subjects into two groups; the obese/
overweight group (BMI ≥ 25 kg/m
2)a n dt h en o n - o b e s e
group (BMI < 25 kg/m
2). Significant association between
an increased number of risk alleles and an increased risk
of T2DM was observed only in the non-obese group (P
< 0.0001 for trend), and not in the obese/overweight
group (P = 0.88 for trend) (Table 4). In addition, we
analyzed the association between obesity/overweight and
T2DM according to quartiles of the risk allele numbers.
Obesity/overweight was a strong predictor of T2DM in
Table 1 Characteristics of the study subjects
All
subjects
T2DM Control P-value
n = 6094 n = 333 n = 417
Age (years) 49.9 ± 8.3 54.4 ± 6.4 53.7 ± 5.1 0.19
BMI (kg/m2) 23.7 ± 3.0 25.0 ± 3.6 23.1 ± 2.7 <
0.0001
SBP (mmHg) 119.9 ±
15.1
126.3 ±
15.6
120.2 ±
16.2
<
0.0001
DBP (mmHg) 76.6 ± 11.4 79.7 ± 11.0 76.6 ± 11.8 0.0004
Total-cholesterol
(mg/dl)
211.9 ±
33.9
212.7 ±
35.0
211.1 ±
31.9
0.77
LDL-cholesterol
(mg/dl)
130.0 ±
30.2
131.2 ±
29.8
130.3 ±
29.9
0.65
HDL-cholesterol
(mg/dl)
57.8 ± 16.3 54.0 ± 16.1 58.7 ± 16.4 0.0002
Triglyceride (mg/dl) 140.0 ±
107.0
160.5 ±
146.7
134.9 ±
110.6
0.012*
Glucose (mg/dl) 100.5 ±
19.8
153.8 ±
40.7
91.8 ± 4.9 <
0.0001*
HbA1c (%) 5.3 ± 0.76 7.3 ± 1.5 5.1 ± 0.33 <
0.0001
T2DM (%) 6.2 100 0 -
Obesity (BMI ≧ 30) (%) 2.6 6.9 1.0 <
0.0001
Overweight (BMI ≧ 25)
(%)
27.0 37.8 21.6 <
0.0001
Hypertension (%) 13.5 29.3 13.2 0.0004
Current smorker (%) 39.8 44.6 41.4 0.62
*Statistical test for triglyceride and glucose levels were calculated on log-
transformed values
P-values between T2DM and contol groups were calculated by t-test or c
2-test
Data are expressed as mean ± SD or percentage
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jects in Q3 and Q4 (≥ 17 risk allele), obesity/overweight
was not a significant risk factor for T2DM (P > 0.05)
(Table 5). These findings indicate that there is an etiolo-
gical heterogeneity of T2DM between obese/overweight
and non-obese subjects.
Discussion
In this population-based case-control study, we have
shown that the cumulative number of risk alleles based
on 17 susceptibility loci for T2DM, identified through
GWAS in Caucasian and Asian populations, was a sig-
nificant risk factor in a Japanese population, although
Table 2 Individual effects of 17 risk alleles of the susceptibility loci on T2DM
Risk allele frequency
Locus db SNP Risk allele T2DM Control OR (95% CI) P-value Power
SLC30A8 rs13266634 C 0.64 0.57 1.95 (1.26-3.04) 0.0026 0.41
CDKN2A/B rs10811661 A 0.61 0.54 1.96 (1.26-3.08) 0.0030 0.41
CDC123 rs11257622 C 0.26 0.21 1.99 (1.21-3.29) 0.0068 0.31
KCNQ1 rs2237892 C 0.64 0.58 1.85 (1.18-2.93) 0.0073 0.40
KCNJ11 rs5219 T 0.41 0.37 1.48 (0.96-2.28) 0.074 0.40
C2CD4A rs7172432 A 0.59 0.54 1.48 (0.95-2.31) 0.081 0.41
IGF2BP2 rs4402960 T 0.34 0.30 1.45 (0.91-2.31) 0.12 0.37
CDKAL1 rs10946403 G 0.50 0.46 1.35 (0.88-2.08) 0.17 0.42
HNF1B rs7501939 T 0.35 0.32 1.35 (0.85-2.14) 0.20 0.38
HHEX rs1111875 G 0.30 0.28 1.25 (0.78-1.98) 0.35 0.36
UBE2E2 rs7612463 C 0.84 0.83 1.31 (0.73-2.36) 0.37 0.25
FTO rs8050136 A 0.22 0.20 1.26 (0.73-2.15) 0.40 0.30
TCF7L2 rs7903146 T 0.06 0.05 1.39 (0.56-3.42) 0.48 0.12
PPARG rs1801282 C 0.97 0.97 1.49 (0.44-5.34) 0.53 0.09
ADAMTS9 rs4607103 C 0.60 0.60 0.81 (0.52-1.25) 0.35 0.40
TSPAN8 rs7961581 C 0.19 0.19 0.95 (0.54-1.69) 0.87 0.29
JAZF1 rs864745 T 0.79 0.80 0.93 (0.55-1.57) 0.78 0.28
Odd ratios and P-values were adjusted for age and BMI under the additive model
Power to detect association was estimated under current sample size and minor allele frequency, assuming OR = 1.2
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Figure 1 Distribution of the cumulative number of risk alleles of 17 T2DM susceptibility loci in T2DM and control subjects.
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i sav e r yi m p o r t a n tr i s kf a c t o rf o rT 2 D M ,h o w e v e r ,
many obese people do not develop T2DM, while many
non-obese people do. In our population-based study,
9.5% of subjects in the obese/overweight group, and
4.7% of subjects in the non-obese group, had T2DM
(data not shown). Impaired insulin resistance and insu-
lin secretion are key determinants of T2DM develop-
ment. It is well known that insulin resistance is
associated with obesity, but insulin secretion is not
affected by body constitution [2,7].
The possibility of etiological heterogeneity of T2DM
between obese/overweight and non-obese subjects can-
not be overlooked. In fact, a significant association
between an increased number of risk alleles and an
increased risk of T2DM was observed only in non-
obese group (P < 0.0001 for trend), and an increased
number of risk alleles was not a significant risk factor
Table 3 Multivariable regression analyses for T2DM
Model 1 Model 2
R
2 0.10 0.11
intercept -10.43 -10.52
Determinant variables b-coefficient SE P b-coefficient SE P
No. of risk alleles 0.18 0.033 < 0.0001 0.18 0.033 < 0.0001
BMI 0.21 0.028 < 0.0001 0.22 0.029 < 0.0001
Age 0.04 0.014 0.0038 0.04 0.014 0.0036
BMI + No. of risk allele -0.029 0.011 0.0080
Model 3 Model 4
R
2 0.089 0.097
intercept -4.41 -1.11
Determinant variables b-coefficient SE P b-coefficient SE P
No. of risk alleles 0.18 0.032 < 0.0001 -0.026 0.11 0.81
Obesity/overweight -1.22 0.20 < 0.0001 -1.19 0.22 < 0.0001
Age 0.04 0.014 0.0047 0.04 0.014 0.0047
Obesity/overweight + No. of risk allele 0.26 0.11 0.015
Model 1 included the number of risk alleles, BMI and age as covariates
Model 2 included the number of risk alleles, BMI, age and the interaction between the number of risk alleles and BMI as covariates
Model 3 included the number of risk alleles, obesity/overweight and age as covariates
Model 4 included the number of risk alleles, obesity/overweight, age and the interaction between the number of risk alleles and obesity/overweight as covariates
SE standard error
Table 4 Relationships between increased number of risk alleles and T2DM
Quartiles
of risk
alleles
All subjects (n = 750)* Obese/overweight (n = 243)** Non-obese (n = 507)**
nn n
T2DM Control OR (95% CI) P-value T2DM Control OR (95% CI) P-
value
T2DM Control OR (95% CI) P-value
Q1 67 137 1 reference 36 25 1 reference 31 112 1 reference
(≦ 14)
Q2 93 130 1.42 (0.93-2.19) 0.11 43 26 1.15 (0.57-2.35) 0.69 50 104 1.71 (1.01-2.91) 0.045
(15, 16)
Q3 98 100 1.95 (1.27-2.99) 0.002 40 31 0.89 (0.44-1.79) 0.75 58 69 3.13 (1.85-5.41) <
0.0001
(17, 18)
Q4 75 50 3.14 (1.93-5.14) <
0.0001
30 12 1.77 (0.77-4.23) 0.18 45 38 4.20 (2.33-7.66) <
0.0001
(≧ 19)
P for
trend
<
0.0001
P for
trend
0.88 P for
trend
<
0.0001
*ORs and P-values on T2DM for all subjects were adjusted with age and BMI
**ORs and P-values on T2DM for obese/overweight and non-obese subjects were adjusted with age
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study (P = 0.88 for trend). However, the power of our
study is insufficient to detect positive association in
obese/overweight group due to the small sample size.
It is necessary to confirm these finding in another
large population.
It was reported previously that risk alleles affecting
insulin action more significantly increase T2DM sus-
ceptibility in obese individuals, while risk alleles affect-
ing insulin secretion confer a T2DM risk in non-obese
individuals [32]. Most of the susceptibility loci analyzed
in the present study appear to influence b-cell function,
such as insulin secretion or b-cell proliferation, which
reasonably explains why the association between an
increased number of risk alleles and an increased risk of
T2DM was observed only in our non-obese subjects.
Furthermore, it is possible that the ability of insulin
secretion is weak for subjects with an increased number
of risk alleles. Unfortunately, we were unable to examine
serum insulin levels of our subjects, and thus, the rela-
tionship between an increased number of risk alleles
and insulin secretion in our subjects remains unclear.
Further examination is required to determine b-cell
function in our subjects.
Recently, several studies indicates the cumulative
number of risk alleles is an important risk factor for
T2DM in Asian population [20,22,33], moreover there
is increasing interest that knowledge about genetic
risk factors may be used to predict the risk of com-
plex disorders such as T2DM [20,22,33-35]. Our data
indicate that both the cumulative number of risk
alleles and obesity/overweigh are important risk fac-
tors for T2DM, but that obesity/overweight is not a
significant risk factor of T2DM in subjects with many
risk alleles (Q3 and Q4; risk allele number ≥ 17).
Most T2DM patients in Japan are characterized by a
low BMI, it might be useful for Japanese population
to count the number of risk alleles of susceptible loci
to improve identification of high-risk subjects. How-
ever, our study is a population-based case-control
study; therefore, we are unable to determine the pre-
dictive power of such susceptibility loci. Further pro-
spective studies are required to translate such
knowledge about genetic risk factors into clinical
practice for prediction and prevention of T2DM in
the general population.
Conclusions
We have shown that the cumulative number of risk
alleles based on 17 susceptibility loci for T2DM, identi-
fied through GWAS in Caucasian and Asian popula-
tions, was a significant risk factor in a Japanese
population, although the effect of each risk allele was
relatively small. In addition, the association between an
increased number of risk alleles and an increased risk of
T2DM was observed only in non-obese group, and not
in obese/overweight group. These data indicate that
there is an etiological heterogeneity of T2DM between
obese/overweight and non-obese subjects. In future,
knowledge about genetic risk factors might be used in
clinical practice for prediction and prevention of T2DM
in the general population.
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Table 5 Effect of obesity/overweight on T2DM according
to quartiles of risk allele numbers
Quartiles T2DM Contrrol OR (95% CI) P-
value
of risk
alleles
(n =
333)
(n =
417)
All subjects obese 149 94 2.78 (2.10-
3.72)
<
0.0001
non-
obese
184 323
Q1 obese 36 25 5.31 (2.79-
10.33)
<
0.0001
(≦ 14) non-
obese
31 112
Q2 obese 43 26 3.59 (1.98-
6.61)
<
0.0001
(15, 16) non-
obese
50 104
Q3 obese 40 31 1.61 (0.89-
2.93)
0.11
(17, 18) non-
obese
58 69
Q4 obese 30 12 2.18 (0.99-
5.02)
0.052
(≧ 19) non-
obese
45 38
ORs and P-values were adjusted with age
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